Ufenamate
Ufenamate (Flufenamic acid butyl ester) is an anthranilic acid-based anti-inflammatory drug that can be used in the study of skin diseases such as acute and chronic eczema, contact dermatitis, diaper dermatitis, miliary rashes and atopic dermatitis. Ufenamate has a certain photoprotective effect, reduces the degree of skin erythema and swelling in the photoaging model, downregulates the expression level of COX-2 and can promote the healing of mouse skull defects by secreting BMP2[1][2][3][4].
Product Specifications
CAS Number
67330-25-0
Product Name Alternative
Flufenamic acid butyl ester; Butyl flufenamate
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
COX; Prostaglandin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Ufenamate.html
Purity
99.89
Solubility
DMSO : ≥ 44 mg/mL
Smiles
O=C(OCCCC)C1=CC=CC=C1NC2=CC=CC(C(F)(F)F)=C2
Molecular Formula
C18H18F3NO2
Molecular Weight
337.34
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
COX-2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
OR5B3 CRISPR Knock Out 293T Cell Line (Human)
Lentiviral mouse Atg12 shRNA (UAS) - Lentiviral mouse Atg12 shRNA (UAS, iRFP) (25)
